Japan’s Environment Ministry plans to step up efforts to prevent elderly people from suffering heatstroke indoors, including at home. It has requested 1 billion yen for related measures under the government’s fiscal 2026 budget.
An expert panel of Japan’s health ministry on Thursday approved over-the-counter sales of a drug to treat erectile dysfunction. It is expected that OTC sales of the drug will help spread opportunities for erectile dysfunction treatment as the male sexual dysfunction has major impacts on society, such as being a factor for declining birthrates.
An expert panel of Japan’s health ministry on Thursday approved over-the-counter sales of a drug to treat erectile dysfunction. It is expected that OTC sales of the drug will help spread opportunities for erectile dysfunction treatment as the male sexual dysfunction has major impacts on society, such as being a factor for declining birthrates.
On the afternoon of the 16th, a man in his 50s was found collapsed in Itami City, Hyōgo Prefecture, and was transported to a hospital, where he was later confirmed dead. According to police, at the time there was a communication outage affecting NTT West, and it is believed that the emergency call was delayed. However, it is not known whether this was directly related to the man’s death.
The research group developed Crunch, short for Connector for Removal of Unwanted Cell Habitat, a protein that binds to unwanted cells to make it easier for macrophages to pick out their target. By modifying the Crunch protein’s structure, it can latch onto different types of unwanted cells. Mice with skin cancer or autoimmune diseases were injected with Crunch protein. The team confirmed that harmful cells, such as cancer cells, either exhibited suppressed growth or were reduced in number.
Japan’s Health, Labor and Welfare Ministry is considering allowing “sleep disorders” to be listed as an official medical department name at hospitals and clinics. The move comes after the Japanese Society of Sleep Research requested the change, citing a rise in conditions such as insomnia and hypersomnia and confusion over where patients should seek treatment. Currently, care is divided among psychiatry, respiratory medicine, and otolaryngology. The ministry’s advisory council aims to reach a decision by March 2026.
An expert panel of Japan’s health ministry has agreed that Aska Pharmaceutical Co. will be given approval to make and sell its emergency contraceptive pill Norlevo without a prescription. At a meeting Friday, the panel also agreed that the product will be classified as a drug that must be taken in the presence of a trained pharmacist for safety reasons. The panel decided not to set an age limit for access. But for individuals under 16, the age of consent to sexual acts, pharmacists would provide guidance as needed. Parental consent would no longer be required. Sales methods will be discussed at a later date.
Japan’s Health, Labor and Welfare Ministry announced Tuesday it will seek a record 34.79 trillion yen in the government’s fiscal 2026 general-account budget, a 1.4% increase from the previous year, largely driven by rising social welfare costs amid the nation’s aging population. The figure may climb further as allocations for key policies, including pay raises for medical and nursing care workers, have yet to be set. The draft budget includes 16.2 billion yen for digital transformation initiatives such as expanding e-prescriptions, and 80.6 billion yen to bolster medical services ahead of 2040, when the country’s demographic aging is expected to peak, with emphasis on addressing regional and specialty doctor shortages.
Japanese medical equipment maker Terumo Corp. said Monday that it will fully acquire OrganOx Ltd., a British maker of equipment to preserve organs for transplantation, for 1.5 billion dollars. The acquisition will allow Terumo to make a full-fledged entry into the organ transplantation market, which is forecast to grow. Set up in 2008 as a spinoff from the University of Oxford, OrganOx developed medical equipment using normothermic machine perfusion, a technology to preserve organs by circulating fluids containing oxygen and nutrients through organs at near-body temperature.
The 8-billion-yen expansion was completed on Aug. 12, the Japanese company said. The expanded facility is expected to go into operation by the end of fiscal 2025. The production and warehouse areas of the factory were connected to improve logistics efficiency.
Barrier Free Japan